Shares of GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 5,401 shares trading hands.
GB Sciences Price Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
See Also
- Five stocks we like better than GB Sciences
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- What is the Nasdaq? Complete Overview with History
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- What is a Special Dividend?
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
